Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Palliat Med. 2010 Feb;13(2):161-9. doi: 10.1089/jpm.2009.0170.

Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needs.

Author information

  • 1Buehler Center on Aging, Health and Society, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA. kgscandrett@northwestern.edu

Abstract

BACKGROUND:

A comprehensive whole-person approach might improve processes and outcomes of care for patients with cancer.

OBJECTIVE:

To assess the ability of NEST13+ (Needs of a social nature; Existential concerns; Symptoms; and Therapeutic interaction), a screening and assessment tool, to identify social, emotional, physical, and care-system needs and to improve clinical outcomes for cancer patients in tertiary care.

DESIGN, SETTING, PATIENTS:

A controlled trial involving 451 patients hospitalized for cancer care at a comprehensive cancer center.

INTERVENTION:

Patients responded to 13 screening questions regarding possible care needs. When an individual response exceeded threshold levels, additional in-depth questions for the relevant need were asked. For patients in the intervention arm, clinical recommendations for each dimension of need were generated based on a previously developed NEST-response-driven menu, and were reported to the clinical team.

MEASUREMENTS:

Documented needs, clinician response, patient perception of goals alignment, and overall quality of palliative care.

RESULTS:

Using the NEST13+ tool in the clinical setting facilitated greater documentation of illness-related needs than routine clinical assessment. Improvement in secondary outcomes was attenuated: changes in the clinician response were modest; changes in outcomes were not significant.

CONCLUSION:

The NEST13+ tool facilitated identification of a wider range of important needs than traditional evaluation, while care outcomes were not improved. Traditional evaluation may need improvement. Future trials of the NEST13+ should focus on more intensive clinician-directed interventions.

PMID:
19821699
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Write to the Help Desk